Filter
1463
Filtered Results: 1463
Text search:
diagnóstico
molecular
Featured
Recommendations
170
New Publications
274
Language
Document type
No document type
661
Guidelines
342
Studies & Reports
233
Manuals
82
Strategic & Response Plan
73
Fact sheets
39
Training Material
12
Situation Updates
12
Resource Platforms
6
Infographics
2
Brochures
1
Countries / Regions
India
78
Latin America and the Carribbean
63
Western and Central Europe
53
Brazil
51
Global
44
Africa
35
Eastern Europe
35
Colombia
29
Kenya
25
South Africa
21
Peru
21
Ethiopia
19
Tanzania
18
Argentina
18
West and Central Africa
17
El Salvador
16
Venezuela
16
Russia
16
Germany
15
East and Southern Africa
15
Paraguay
14
Mozambique
13
Senegal
11
Uganda
11
Malawi
11
Sierra Leone
10
Nigeria
10
Bolivia
10
Chile
10
South–East Asia Region
10
Asia
10
Philippines
9
Zambia
9
Ecuador
9
Angola
9
Liberia
8
Rwanda
8
Ukraine
8
Bangladesh
7
Ghana
6
Middle East and North Africa
6
Congo, Democratic Republic of
5
Zimbabwe
5
Nepal
5
Namibia
5
Eastern Europe and Central Asia
5
Spain
5
USA
4
Cameroon
4
Indonesia
4
Myanmar / Burma
4
Western Pacific Region
4
Guinea
3
Burkina Faso
3
Haiti
3
Pakistan
3
Benin
3
Eswatini/ Swaziland
3
Uruguay
3
France
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Syria
2
Cambodia
2
Dominican Republic
2
Honduras
2
Guatemala
2
Georgia
2
North America
2
Mali
1
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Jordan
1
Turkey
1
Chad
1
Thailand
1
Gambia
1
China
1
Mauritania
1
Cuba
1
Botswana
1
Libya
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Palestine
1
Italy
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Tajikistan
1
Estonia
1
Romania
1
Turkmenistan
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
517
Clinical Guidelines
194
Pharmacy & Technologies
60
Public Health
53
Key Resources
19
Women & Child Health
18
Capacity Building
4
Toolboxes
TB
367
COVID-19
230
AMR
94
NTDs
90
HIV
75
Rapid Response
66
Mental Health
60
Ebola
34
Zika
28
Planetary Health
25
Pharmacy
23
NCDs
16
Polio
12
Refugee
12
Caregiver
9
Cholera
8
Global Health Education
6
Specific Hazards
5
Disability
4
Natural Hazards
4
Health Financing Toolbox
4
Conflict
3
Исследование этого года основано на предыдущем отчете. В нем отслеживается утверждение последних стратегий, руководств и методов в пяти сферах: диагностика и иссл...
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579
This is the first national Policy to combat AMR in Cambodia. It was developed based on conclusions and recommendations of a country situaytion analysis.
Accessed Febr.6, 2020
Accessed Febr. 6, 2020
This FY 2017 Malaria Operational Plan presents a detailed implementation plan for Senegal, based on the strategies of PMI and the National Malaria Control Program (NMCP) strategy. It was developed in consultation with the NMCP and with the participation of national and international partners involve...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance.
T...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat antimicrobial resistance (AMR). The Africa Centres fo...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef...
A new respiratory infectious disease, COVID-19, caused by a new coronavirus called SARS-CoV-2, emerged in early December 2019. Since then, the virus has spread to India and 106 other countries in Asia, Europe, North America, Africa, and Oceania. On March 11, the World Health Organization (WHO) decl...
Document d’information scientifique
24 avril 2020
Le développement d’une immunité face à un agent pathogène à la suite d’une infection naturelle comporte plusieurs étapes et prend généralement une à deux semaines. Une infection virale entraîne immédiatement une réponse immunit...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen detection tests (RADT) to their ...
